Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

A. Keith Stewart, S. Vincent Rajkumar, Meletios Α. Dimopoulos et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo et al. · The Lancet Oncology · 2015 · 849 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

Alexandre Loupy, Carmen Lefaucheur, Déwi Vernerey et al. · New England Journal of Medicine · 2013 · 833 citations · Full text

Life Sciences, Immunology, Surgery +17

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease

Paul J. Michaels, Maria L. Espejo, Jon Kobashigawa et al. · The Journal of Heart and Lung Transplantation · 2003 · 389 citations

Life Sciences, Cardiology, Immunology +17

Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information

Anat R. Tambur, N Herrera, Kelley M.K. Haarberg et al. · American Journal of Transplantation · 2015 · 259 citations

Life Sciences, Immunology, Clinical Immunology +7